hyoscine hydrobromide
hyoscine hydrobromide
CLINICAL USE
Motion sickness Premedication Palliative care
DOSE IN NORMAL RENAL FUNCTION
Motion sickness: Oral: 300 mcg 30 minutes before start —of journey then 300 mcg every 6 hours if required; maximum 3 doses in 24 hoursTopical: 1 patch 5–6 hours before —journey, replace after 72 hoursPremedication (SC/IM): 200–600 mcg 30–60 minutes before anaesthesiaSC Infusions: Excessive secretions (patch can also be used for this indication): 0.6–2.4 mg over 24 hoursBowel colic: 20–60 mg over 24 hours
PHARMACOKINETICS
Molecular weight                           :438.3 %Protein binding                           :10 %Excreted unchanged in urine     : 2 (1 – oral, 34 – transdermal) Volume of distribution (L/kg)       :No datahalf-life – normal/ESRD (hrs)      :8 DOSE IN RENAL IMPAIRMENT
GFR (mL/MIN)
20 to 50     : Dose as in normal renal function 10 to 20     : Dose as in normal renal function <10           : Dose as in normal renal function DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES
CAPD                :Dialysed. Dose as in normal renal function HD                     :Dialysed. Dose as in normal renal functionHDF/high flux   :Dialysed. Dose as in normal renal functionCAV/VVHD      :Not Dialysed. Dose as in normal renal function IMPORTANT DRUG INTERACTIONS
Potentially hazardous interactions with other drugsNone known ADMINISTRATION
Reconstition
– Route
Oral, topical, SC, IM Rate of Administration
–Comments
– OTHER INFORMATION
Only 2–8% of oral dose is absorbed
See how to identify renal failure stages according to GFR calculation
See how to diagnose irreversible renal disease
Home